DEVICE CATEGORY · SER
Immunohistochemistry Assay, Antibody, Met
The MET antibody is a qualitative immunohistochemical antibody intended to identify MET protein expression in human clinical tissue specimens. The MET antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VENTANA MET (SP44) RxDx AssayP240037/S003 | Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) | PMA supplement | Oct 23, 2026 | FDA |
| Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) | PMA approval | May 14, 2025 | FDA |
Source information
Follow the FDA links to view the original records.

